What Has Been the Growth of the Anorectal Disorders Treatment Market So Far?
The anorectal disorders treatment market has seen considerable growth due to a variety of factors.
• The market size for anorectal disorder treatments has witnessed robust growth in the past few years. It's projected to escalate from $4.2 billion in 2024 to approximately $4.49 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%.
The expansion during the historical period has been driven by factors such as an aging population, lifestyle aspects, heightened awareness, and the introduction of non-surgical approaches.
What Are the Future Growth Projections for the Anorectal Disorders Treatment Market?
The anorectal disorders treatment market is expected to maintain its strong growth trajectory in upcoming years.
• There is a strong prediction of substantial growth in the market for anorectal disorders treatment in the upcoming years. The market's worth is forecasted to escalate to $5.77 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 6.5%.
The projected growth during the forecast period can be traced back to the increasing requirement for patient education, shifts in dietary habits, the need for telemedicine, and ongoing research and development activities. The prediction period is expected to witness major trends like technological progress, enhancements in endoscopy and imaging, and public health initiatives.
What Are The Core Factors Supporting Growth In The Anorectal Disorders Treatment Market?
The growth of the anorectal disorder treatment market is anticipated to be fueled by an increasing geriatric population. This demographic, classified as individuals aged 65 and above, is more likely to need treatment for anorectal disorders. Such treatment offers these older individuals not only effective pain management but also hygiene enhancement, prevention of recurrence, and an overall boost in their quality of life. To provide perspective, figures from the World Health Organization from October 2022 indicate that by 2030, globally, one in every six individuals would be 60 or above, and the total number of elderly people is projected to hit 2.1 billion by 2050. Consequently, this increase in the aging population drives the growth of the anorectal disorder treatment market. Market Driver for Anorectal Disorders Treatment: Growth Stimulated by Rising Incidence of Colorectal Cancer
What Are The Major Segments Within The Global Anorectal Disorders Treatment Market?
The anorectal disorders treatment market covered in this report is segmented –
1) By Treatment: Drugs, Surgery, Other Treatment
2) By Disease: Diarrhea, Hemorrhoid, Abscesse, Fistula, Itching, Other Disease
3) By Route Of Administration: Oral, Parenteral, Rectal, Other Route of administration
4) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Drugs: Topical Agents, Oral Medications, Rectal Suppositories
2) By Surgery: Hemorrhoidectomy, Fistulotomy, Sphincterotomy, Other Surgical Procedures
3) By Other Treatment: Lifestyle Modifications, Dietary Changes, Physical Therapy, Minimally Invasive Procedures
Pre-Book The Anorectal Disorders Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Anorectal Disorders Treatment Market?
Renowned businesses in the market for anorectal disorder treatments are launching new drugs and obtaining approval for them to consolidate their hold on the market. The creation of these new medications broadens the range of anorectal treatments available, offering patients more specialized and effective options, like Budesonide 2mg Rectal Foam. For example, Padagis US LLC, an American pharmaceutical company, in April 2023, released their FDA-approved Budesonide 2mg Rectal Foam (a generic equivalent to Uceris) for the treatment of anorectal disorders. The FDA is a government agency situated in the US. Uceris, a prescription corticosteroid medication, is used to manage active, mild-to-moderate ulcerative colitis, a lasting inflammatory bowel disease (IBD) impacting the rectum and large intestine, extending from the rectum to the sigmoid colon.
Who Are the Key Players In The Anorectal Disorders Treatment Market?
Major companies operating in the anorectal disorders treatment market are:
• Cardinal Health Inc.
• Cigna Corporation.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Novartis AG
• AstraZeneca PLC
• Merck and Co. Inc.
• Abbott Laboratories
• GlaxoSmithKline PLC
• Medtronic PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• McKesson Corporation
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Mylan N.V.
• B. Braun Melsungen AG
• Bausch Health Companies Inc.
• Olympus Corporation
• Sun Pharmaceutical Industries Ltd.
• Ethicon Inc.
• Coloplast A/S
• Teleflex Incorporated
• Cook Medical Inc.
• ConvaTec Group PLC
• Lupin Limited
• Akorn Inc.
• NATCO Pharma Limited.
What Is The Most Dominant Region In The Anorectal Disorders Treatment Market?
North America was the largest region in the anorectal disorders treatment market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in anorectal disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
